BBB National Programs

The National Advertising Division will refer Kendal to appropriate government and state agencies and advertising platforms for review and possible enforcement action after the company elected not to participate in the compliance inquiry.

Read the case decision summary: hubs.la/Q04DCqxh0

On Fridays, our Weekly Case Decision Digest delivers the latest published decisions from across BBB National Programs, including:
• The National Advertising Division (NAD)
• The National Advertising Review Board (NARB)
• The Direct Selling Self-Regulatory Council (DSSRC)
• The Digital Advertising Accountability Program (DAAP)
• The Children’s Advertising Review Unit (CARU)

Stay current on every outcome in one weekly email: hubs.la/Q04DrWSP0

The National Advertising Division recommended that Good Life Meds discontinue the challenged express health benefit and personalization claims for its compounded Tirzepatide+ products and modify its advertising to avoid conveying unsupported implied claims about product safety, efficacy, weight loss results, and personalization.

Read the case decision summary: hubs.la/Q04DjKMJ0

Is your content directed to children? Our Children’s Advertising Review Unit (CARU) offers Age CARD, an independent, documented determination of whether your content is child-directed, a decision that carries real COPPA consequences. Get clarity before regulators ask.

Set up a consultation today: hubs.la/Q04DgxmM0

National Partners are invited to join us on December 2 for our upcoming National Advertising Division (NAD) Committee meeting, where industry leaders and subject matter experts will discuss emerging developments in advertising law, recent NAD trends, and practical insights for advertisers.

Learn more about becoming a National Partner: hubs.la/Q04Cw6HJ0